Project success depends on an experienced team, clearly defined objectives, and thoughtful planning. We listen carefully, ensuring both the drug target and clinical product profiles are completely understood. Then, a comprehensive research plan is developed outlining program scope, team formation, responsibilities, milestones, best estimate of costs, and timelines.
A dedicated team of specialized scientists begin tackling the programs’ methodological and technical requirements. These efforts may involve collaboration between our bioengineers, our protein sciences, or our antibody discovery groups to ensure comprehensive target and hit identification and evaluation.
We don't discover proteins and antibodies, we discover drugs. Often candidate compounds require optimized properties such as stability, efficacy, specificity, or expression. Our bioinformatics, yeast display, protein sciences, and analytical groups will evaluate compounds for therapeutic (“drug-like”) properties and develop a solution that bolsters success in the clinic.
We work with our partner to identify the critical in vivo demonstrations necessary to identify a preclinical candidate. We prepare high-quality materials for in vivo studies, develop customized PK and PD assays, and evaluate the results of the study with complete analytics capabilities.
We are there to provide continued support to our partners as the project moves through preclinical development and into clinical development. All the data is captured in our electronic notebooks and detailed results and reports are available for future reference.